🔥Telegram İfşa

Dans ma BAL, don du voisinage pour CHU de Nantes des petits gestes reconfortants #solidarité avec les soignants #civilité

On the universality of facial expressions (and emotions): occurrence of 16 expressions in 6M videos from 144 countries was examined using machine learning; facial expressions had distinct associations with a set of contexts. nature.com/articles/s4158… via nature Inventive and cool.

Very excited to share our new study out today in Journal of Clinical Oncology, deciphering the biological basis for the Diagnosis to Treatment Interval (DTI) in lymphoma and relationship to #ctDNA tumor burden. #lymsm ascopubs.org/doi/abs/10.120…

Excited to share our recent work with Tanaya Shree in @BloodJournal on divergent evolution in lymphoma. Grateful for mentorship by Ron Levy and the collaboration with the Hanlee Ji lab & all coauthors including Anuja Sathe & Grady Day #lymsm Stanford Medicine ashpublications.org/blood/article-…

Excited for the opportunities to apply this next generation of MRD technologies for more sensitive detection of lymphomas and other cancers.

#Nomination | « Par ses valeurs et son histoire, l’Institut Curie porte une profonde dimension humaniste que je m’engage à poursuivre. » A compter du 1er septembre, le Pr Steven Le Gouill 🧑‍⚕️ prend la direction de l’Ensemble Hospitalier de l’Institut Curie. ⬇️

Really chuffed to share our latest work from Sanjana Lab out in @nature today (nature.com/articles/s4158…). We tested >12,000 genes to find positive regulators of T cell proliferation to be used for next-gen #immunotherapies. A thread...

The reward for a 6am bike ride in winter is the stunning #sunrise in this case the view from Kings Park over #perth #perthisok photo credit: Mark Johnson

EHA Abs#S262, CART ttmt finally taking-off for patients suffering of PTCL. A CD70 directed allogeneic CART(CTX130). 80% ORR at higher doses, and a chance to bridge to Allografting.

#JournéeMondialedesLymphomes 📣 #JMLs2022 organisée par ELLyE l’Association #Lymphomes #LLC et soutenue par Lysa Lymphoma 🎯 Informer sur la maladie, et sensibiliser le grand public sur le 1er #cancerdusang à travers des réunions d’information dans 22 villes en France #MoisDesCancersDuSang #JML2022 #JMLS

SCHOLAR-2 results out ⏩⏩ N=240 R/R #MCL pts treated with BTKi-based 2012-18 From time of stopping BTKi: mOS 0.36m  in 90 pts if no post-BTKi Rx mOS 11.4m in 148 pts post-BTKi therapy (excluding CART). Plenty of work to be done in post cov. BTKi space in #MCL #lymsm #SCHOLAR2

Pleased to announce that our review of molecular monitoring in lymphoma is now open access, with Ash Alizadeh, MD/PhD 🇺🇸 Stefan Alig Benoit T annualreviews.org/eprint/KAZM3N7…

Print version out this week in Cancer Discovery ! Looking forward to seeing everyone at International Conference on Malignant Lymphoma AACR next week!

Do you remember the vigorous April 2023 discussion after #ODAC vote & #FDA approval of #polatuzumab for #DLBCL & #HGBCL? Well, with Adam C Palmer & Dave Kurtz, we now tackle this more through meta-analysis NEJM… 1/n nejm.org/doi/full/10.10…

Honored to share our newly published manuscript ascopubs.org/journal/jco which demonstrates that circulating tumor DNA (ctDNA) by PhasED-Seq offers the most precise definition of remission after frontline therapy for patients with large B-cell lymphoma (LBCL) out now in Journal of Clinical Oncology.

[Journées du LYSA] 📸 Retour en image sur la session Lymphome à cellules du Manteau Avec Morgane Cheminant, Clement Bailly, Steven Le Gouill, Yannick Le Bris, Benoit Tessoulin et Olivier Hermine #LYSAToulouse25 #LYSA #lymphome #lymphoma #rechercheclinique #research

[Journées du LYSA] 📸 Retour en images sur la session ELLyE l’Association #Lymphomes #LLC « Plus loin, ensemble » avec Clotilde Genon et Franck Fontenay #LYSAToulouse25 #ELLYE #FranceLymphomeEspoir #lymphome #lymphoma #rechercheclinique

7 Substances Added to 14th Report on Carcinogens, especially viruses linked to lymphomas. No news but official. niehs.nih.gov/news/newsroom/…

Here is #ASH16 #leonardlist 8 Abst 145 LeGouill Survival benefit of maint rituximab post SCT mantle cell #lymphoma ash.confex.com/ash/2016/webpr…